Please cite this article as: C. Jenei, et al., High shear stress on the background of clinical restenosis at the site of step-down phenomenon after drug eluting stent implantation, Cor et Vasa 58 (2016) e518-e521 as published in the online version of Cor et Vasa available at
Introduction
It is generally accepted that low or/and oscillating wall shear stress (WSS) has a role in the development of restenosis after coronary stent implantation but there is only a limited amount of data about systematic follow-up investigation of clinical endpoints and WSS calculation in clinical population after stent implantation.
Description of the case
A 49-year-old female diabetic patient who had stent implantation in the left circumfl ex coronary (LCx) artery was admitted because of recurrent anginal symptoms. Coronary angiography revealed a patent LCx stent while a long 50-60% stenosis was detected in the medial segment of the left anterior descending artery (LAD). Fractional fl ow reserve (FFR) measurement during maximum vasodilatation proved the hemodynamic signifi cance of the lesion (FFR: 0.77). Therefore, a drug-eluting stent (DES) was implanted (3.5/28 mm Promus Element) which improved the FFR to 0.86. The resting pressure ratio was detected to be 0.92 ( Fig. 1 ).
After 6 months repeated coronary angiography was performed because of reoccurrence of the symptoms of effort angina pectoris showing severe restenosis at the distal edge of the DES ( Fig. 2A and 2B ). This lesion was successfully treated by another DES implantation. A retrospective modeling was performed to investigate the possible effect of the step-down at the distal edge of the previous DES on the wall shear stress (WSS) conditions ( Fig. 2A and 2C) using fl uid dynamic analysis by the ANSYS CFX 15.0 software. The investigated vessel geometry was generated on the basis of the 3D anatomical reconstruction of the target vessel segment by a dedicated 3D QCA software package (QAngio XA 3D Research Edition 1.0, Medis Specials bv, Leiden, the Netherlands) software and the pressure traces during a cardiac cycle after the previous DES implantation at resting condition.
Blood was considered as a homogeneous, non-Newtonian fl uid modeled by the Carreau-Yasuda shear dependent viscosity equation with the same parameters as in Boyd et al. [1, 2] , and a density of 1050 kg/m 3 . Blood fl ow was assumed to be laminar and incompressible. The arterial wall was considered to be rigid and no-slip conditions were applied at the baseline luminal surface. Shear stress at the reconstructed poststent luminal surface was calculated as the product of blood viscosity and the gradient of blood velocity at the wall during the cardiac cycle (Fig. 3) .
The kinetics of the WSS was calculated along the cardiac cycle (Video 1). The changes in direction and magnitude of WSS could be approximated by the oscillatory shear index OSI (its values may range from 0 to 0.5 -0 being a total unidirectional WSS, and 0.5 being a total bidirectional shear fl ow) [2] . The OSI and the average WSS were calculated at 5 points of the reconstructed vessel (1-3: within the stent, 4-5 distal to the stent) ( Fig. 2C and Table 1 ).
Supplementary Video 1 related to this article can be found, in the online version, at http://dx.doi.org/10.1016/j. crvasa.2015.08.005.
Contrary to the previous reports the greatest amplitude and the greatest average WSS of the arterial WSS had been detected where the restenosis developed later at the site of the step-down. It is also in contradiction to the previous calculations that the oscillation of the WSS was the lowest at the site of restenosis compared to the other points ( Fig. 2C and Table 1 ).
Discussion
According to published data the normal average WSS in coronary arteries during resting condition ranges from 0.5 to Table 1 -The average wall shear stress (WSS) and the oscillatory shear index (OSI) values at points 1-5 (according to Fig. 2C) 7 Pa and depends on the applied calculation method [3] . The pathological low WSS (inducing intimal hyperplasia or plaque formation) was reported to be with values below 0.5-1 Pa [4] . However, the pathologically high WSS is less defi ned. Fan et al. reported that plaque wall thickness correlated positively with fl ow shear stress, but there are no available data about the potential role of high WSS in restenosis, despite the fact that higher sheer stress values can be seen frequently in areas of turbulent fl ow considered also deteriorating for normal intimal function/formation [5] . After stent implantation, adequately functionally neointimal formation is the prerequisite of the normal healing process. Previous studies stated that low WSS was associated with increased neointimal hyperplasia (NIH), but in the present state of the research it is not clarifi ed that when the compensatory NIH re-establishes the WSS to physiological level and when it overshoots into the clinical restenosis. The NIH was used as a surrogate end point and not a clinical one [6] [7] [8] [9] [10] [11] in most of the publications raising the question whether the detected NIH is a part of the healing process after stent implantation or a predictor of a later restenosis.
To the best of our knowledge only Thury et al. had reported one case showing clinical restenosis requiring repeat revascularization as a consequence of the intimal thickening at the site of step-up phenomenon with low and oscillating WSS [12] . In contrast to that observation, we found very high resting average WSS (18.54 Pa) with low oscillation in our case at the site of the later restenosis. The different results may be explained by the different shear patters at the site of the step-up and step--down formations, and highlights the possibility that the extremely high WSS can also associate to restenosis at the distal edge of the stent.
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